Skip to main navigation

Top bar

Biogen.com Information Request Sign up for Alerts Search

Investor Relations

Overview

News

Events Presentations

SEC Filings Annual Reports

Stock Quote & Chart Analyst Coverage Investor FAQs

Governance Documents Committee Composition & Charters Leadership Code of Business Conduct Contact the Board

News

News

News Category

Year

April 24, 2017

Final Phase 3 Study Data Show SPINRAZA® (nusinersen) Significantly Improved Motor Function in Children with Later-Onset Spinal Muscular Atrophy

April 24, 2017

TECFIDERA® and TYSABRI® Data Demonstrate Improved Outcomes with Early MS Treatment

April 21, 2017

Biogen’s SPINRAZA® (nusinersen) Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy

April 18, 2017

Biogen Highlights Advances from Its Neurology Research Programs and Portfolio of Innovative Medicines at AAN Congress

April 13, 2017

Biogen Licenses Phase 2 Anti-Tau Antibody from Bristol-Myers Squibb

March 28, 2017

Biogen to Present Data at the 13th International Conference on Alzheimer’s and Parkinson’s Diseases

March 27, 2017

Biogen to Report First Quarter 2017 Financial Results on April 25, 2017

March 16, 2017

Biogen Appoints Anirvan Ghosh Senior Vice President, Research and Early Development

February 28, 2017

Biogen to Present at the Cowen & Company 37th Annual Health Care Conference

February 15, 2017

Biogen to Present at the 2017 RBC Capital Markets Global Healthcare Conference

Pagination

First page
Previous page
…
Page 8
Page 9
Page 10
Page 11
Current page 12
Page 13
Page 14
Page 15
Page 16
…
Next page
Last page

Displaying 111 - 120 of 653

Footer

Investors
Careers
Our Stories
Contact Us

Follow us

Bottom

Privacy Policy
Terms & Conditions
Forward-Looking Statements
Community Guidelines

Investor Relations

Overview

News

Events & Presentations

Events
Presentations

Financials

SEC Filings
Annual Reports

Stock Information

Stock Quote & Chart
Analyst Coverage
Investor FAQs

Corporate Governance

Governance Documents
Committee Composition & Charters
Leadership
Code of Business Conduct
Contact the Board

Top bar

Biogen.com

Information Request

Sign up for Alerts

Search

Follow us